Source:http://linkedlifedata.com/resource/pubmed/id/17182240
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-5
|
pubmed:abstractText |
Interleukin-10 (IL-10) is a multifunctional cytokine acting as inhibitor of inflammatory and immune responses as well as tumour induced angiogenesis. A common [ATA] haplotype formed by polymorphisms at positions -1082, -819 and -592in the promoter of the IL-10 gene is a strong determinant for IL-10 expression. The presence of this haplotype can be determined by analysis of the -592C>A polymorphism. To analyse the role of the IL-10 [ATA] haplotype in prostate cancer we performed a case-control study including 561 prostate cancer patients and 561 male, age-matched, control subjects without malignant disease. The IL-10 -592C>A polymorphism was determined by a 5'-nuclease assay (TaqMan). IL-10 -592 CC, CA and AA genotype frequencies were not significantly different between patients (53.6%, 40.0%, 6.4%) and controls (54.3%, 39.6%, 6.1%; p=0.96). IL-10 genotypes were furthermore not associated with tumour characteristics such as histological grade, T stage, PSA levels at diagnosis, or age at diagnosis. Therefore we conclude that the IL-10 -592C>A promoter polymorphism, tagging the IL-10 low-producer [ATA] haplotype, is not associated with risk for prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
472-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17182240-Aged,
pubmed-meshheading:17182240-Haplotypes,
pubmed-meshheading:17182240-Humans,
pubmed-meshheading:17182240-Interleukin-10,
pubmed-meshheading:17182240-Male,
pubmed-meshheading:17182240-Polymorphism, Genetic,
pubmed-meshheading:17182240-Promoter Regions, Genetic,
pubmed-meshheading:17182240-Prostatic Neoplasms,
pubmed-meshheading:17182240-Risk Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
|
pubmed:affiliation |
Department of Therapeutic Radiology and Oncology, Medical University of Graz, Auenbruggerplatz 32, 8036 Graz, Austria. tanja.eder@klinikum-graz.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|